Sodium Sulfacetamide and Sulfer Emulsion

Manufacturer
Trifluent Pharma
Effective date
2025-10-15
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 22:01:28

Label at a glance#

ProductSodium Sulfacetamide and Sulfer Emulsion
Active ingredientSULFACETAMIDE SODIUM, SULFUR
Label structure12 sections

Dosage and administration

Apply Sodium Sulfacetamide 10% and Sulfur 1% Emulsion once or twice daily to affected areas, or as directed by your physician. Wet skin and liberally apply to areas to be cleansed. Massage gently into skin for 10-20 seconds, working into a full lather, rinse thoroughly and pat dry. If drying occurs, it may be controlled by rinsing off Sodium Sulfacetamide 10% and Sulfur 1% Emulsion sooner or using less often.

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

NDC 773352-750-01

Sodium Sulfacetamide 10 % and Sulfur 1% Emulsion

Rx Only

FOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE.

Net. Wt. 177 mL

Active ingredients: Sodium Sulfacetamide 10% and Sulfer 1%

Indications: For the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis.

Directions: Wash affected areas once or twice daily or as directed by a physician. Wet skin and liberally apply to areas to be cleansed, message gently into skin for 10-20 seconds, working into a full lather, rinse thoroughly and pat dry. If drying occurs, it may be controlld by rinsing cleanser off sooner or using less often. See attached booklet for full prescribing information.

Warning: for external use only.

Avoid Contract with eyes.

KEEP OUT OF REACH OF CHILDREN.

Keep bottle tightly closed.

Store at controlled room temperatures, 15º - 30ºC (59º - 86º F).

Protect from freezing.

All prescription substitutions and or recommendations using this product shall be made subject to the state and federal statutes as applicable. NOTE: This is not an Orange Book product. No representation is made as to generic status or bioequivalency. Please see attached booklet fo more information.

Distributed by:

Trifluent Pharma, LLC

San Antonio, TX 78212

Rev. 07-255

Rx Only

DESCRIPTION

DESCRIPTION SECTION

Each gram of Sodium Sulfacetamide 10% and Sulfur 1% Emulsion contains 100 mg of sodium sulfacetamide and 10 mg of sulfur in a formulation containing Butylated Hydroxytoluene, Cetyl Alcohol, Citric Acid, Cocamidopropyl
Betaine, Disodium EDTA, Glycerin, Glyceryl Stearate SE, PEG-100 Stearate, Phenoxyethanol, Purified Water, Sodium Laureth Sulfate, Sodium Thiosulfate, Stearyl Alcohol, Triacetin, Xanthan Gum.

Sodium sulfacetamide is a sulfonamide with antibacterial activity while sulfur acts as a keratolytic agent. Chemically sodium sulfacetamide is N-[(4-aminophenyl) sulfonyl]-acetamide, monosodium salt, monohydrate. The structural formula is:

Chemical StructureChemical Structure

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

The most widely accepted mechanism of action of sulfonamides is the Woods-Fildes theory, which is based on the fact that
sulfonamides act as competitive antagonists to para-aminobenzoic acid (PABA), an essential component for bacterial growth. While absorption through intact skin has not been determined, sodium sulfacetamide is readily absorbed from the
gastrointestinal tract when taken orally and excreted in the urine, largely unchanged. The biological half-life has variously been reported as 7 to 12.8 hours. The exact mode of action of sulfur in the treatment of acne is known, but it has been
reported that it inhibits the growth of Propionibacterium acnes and the formation of free fatty acids.

INDICATIONS

INDICATIONS & USAGE SECTION

Sodium Sulfacetamide 10% - Sulfur 1% Emulsion is indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

Sodium Sulfacetamide 10% and Sulfur 1% Emulsion is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation.

Sodium Sulfacetamide 10% and Sulfer 1% Emulsion is not to be used by patietns with kidney disease.

WARNINGS

WARNINGS SECTION

Although rare, sensitivity to sodium sulfacetamide may occur.
Therefore, caution and careful supervision should be observed when prescribing this
drug for patients who may be prone to hypersensitivity to topical sulfonamides.
Systemic toxic reactions such as agranulocytosis, acute hemolytic anemia, purpura
hemorrhagica, drug fever, jaundice, and contact dermatitis indicate hypersensitivity
to sulfonamides. Particular caution should be employed if areas of denuded or abraded skin are involved.

FOR EXTERNAL USE ONLY. Keep away from eyes. Keep out of reach of children.
In case of accidental ingestion contact a poison control center immediately. Keep
container tightly closed.

PRECAUTIONS

PRECAUTIONS SECTION

-

General

GENERAL PRECAUTIONS SECTION

If irritation develops, use of the product should be discontinued and appropriate therapy instituted. Patients should be carefully
observed for possible local irritation or sensitization during longterm therapy. The object of this therapy is to achieve desquamation without irritation, but sodium sulfacetamide and sulfur can cause reddening and scaling of the epidermis. These
side effects are not unusual in the treatment of acne vulgaris, but patients should be cautioned about the possibility.

Information for patients

INFORMATION FOR PATIENTS SECTION

Avoid contact with eyes, eyelids, lips and mucous membranes. If accidental contact occurs, rinse with water. If excessive irritation
develops, discontinue use and consult your physician.

Carcinogenesis, Mutagenesis and Impairment of Fertility

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION

Long-term studies in animals have not been performed to evaluate carcinogenic potential.

PREGNANCY

PREGNANCY SECTION

-

Category C

SPL UNCLASSIFIED SECTION

Animal reproduction studies have not been conducted with Sodium Sulfacetamide 10% and Sulfer 1% Emulsion. It is not known whether Sodium Sulfacetamide 10% and Sulfer 1% Emulsion can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Sodium Silfacetamide 10% and Sulfer 1% Emulsion should be given to a pregnant woman only if clearly needed.

NURSING MOTHERS

NURSING MOTHERS SECTION

It is not known whether sodium sulfacetamide is excreted in the human milk following topical use of Sodium Sulfacetamide 10% and Sulfur 1% Emulsion. However, small amounts of orally administered sulfonamides have been reported to be eliminated in human milk. In view of this and because many drugs are excreted in human milk, caution should be exercised when Sodium Sulfacetamide 10%
and Sulfur 1% Emulsion is administered to a nursing woman.

PEDIATRIC USE

PEDIATRIC USE SECTION

Safety and effectiveness in children under the age of 12 have not been established.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

Although rare, sodium sulfacetamide may cause local irritation.


Call your doctor for medical advice about side effects. To report a serious
adverse event, please contact Trifluent Pharma, LLC at 1-888-927-5191.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Apply Sodium Sulfacetamide 10% and Sulfur 1% Emulsion once or twice daily to affected areas, or as directed by your physician.
Wet skin and liberally apply to areas to be cleansed. Massage gently into skin for 10-20 seconds, working into a full lather, rinse
thoroughly and pat dry. If drying occurs, it may be controlled by rinsing off Sodium Sulfacetamide 10% and Sulfur 1% Emulsion sooner or using less often.

HOW SUPPLIED

HOW SUPPLIED SECTION

Sodium Sulfacetamide 10% and Sulfur 1% Emulsion is available
in 177 mL bottles, NDC 73352-750-01.

STORAGE AND HANDLING

STORAGE AND HANDLING SECTION

Store at controlled room temperature, 15° - 30°C (59° - 86°F). Protect from freezing.

KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.

SPL UNCLASSIFIED SECTION

Distributed by

Trifluent Pharma, LLC.

San Antonio, Tx 78213

All prescription substitutions and or recommendations using this product shall be made subject to state and federal statutes as applicable. Note: This is not an Orange Book product. No representation is made as to the generic satus or bioequivalency. Each person recommending a prescription substitution using this product shall make such recommendationss based on each such person's professonal opinion and knowlege, upon evaluating the active ingredients, excipients, inactive ingredients and chemical formulation provided herein.

PRINCIPAL DISPLAY PANEL - 177 mL Bottle Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 73352-750-01

Rx Only

Sodium Sulfacetamide 10% Sulfur 1% Emulsion

FOR EXTERNAL USE ONLY
NOT FOR OPHTHALMIC USE

Net Wt. 177mL

Trifluent Pharma, LLC

San Antonio TX 78213

LabelLabel

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
999604sulfacetamide sodium 10 % / sulfur 1 % Medicated Liquid SoapPSN2
999604sulfacetamide sodium 100 MG/ML / sulfur 10 MG/ML Medicated Liquid SoapSCD2
999604sulfacetamide sodium 10 % / sulfur 1 % Medicated Liquid SoapSY2

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
SULFACETAMIDE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-130373352750016GTIN-13: 0373352750016
EAN-13: 0373352750016
GTIN-12: 373352750016
UPC-A: 373352750016
GTIN storage (14 digits): 00373352750016
Label SSS.jpg

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
4073022c-5d5d-48f5-82ed-091ad146a4b2Product name120171211
9ffbd0ae-0bce-c086-b707-f0da5f8cd7c5Product name120150828
0304b7d2-7a07-d53b-750f-36012ae6612eProduct name120140508
64c0cc7e-6478-3ca1-8cd7-9a1251d5a3f6Product name120140508
9ae74339-0a3d-82e9-5dd1-88bd2607bd6bProduct name120140508
e44e38a9-2d9e-b0e2-cce9-490554639f3dProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
73352-750-01Sodium Sulfacetamide and Sulfer Emulsion177 mL in 1 BOTTLEEMULSION1772

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
73352-750-01ML - Milliliter73352-75092c77bf0-fc73-4798-b347-c7ce7feaea2812025-11-13

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 20 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
73352-75073352-750-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 17 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Sodium Sulfacetamide and Sulfer EmulsionSODIUM SULFACETAMIDE AND SULFERTrifluent Pharma40601d03-aea0-b0a6-e063-6394a90a16982025-10-15Warnings, Adverse reactionsExact identifier
ndc (package): 73352-750-01
ndc (product): 73352-750
ndc11 (package): 73352075001
spl id: 41396a22-cc34-94f2-e063-6294a90afb65
spl set id: 40601d03-aea0-b0a6-e063-6394a90a1698

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.